Proteolysis-targeting chimera (PROTAC) BET degraders (e.g., SPP-ARV-825) achieve selective BRD4 depletion, suppress MGMT, and reprogram tumor-associated macrophages (TAMs) toward pro-inflammatory states (72, 73). The gene discussed is MGMT; the disease is neoplasm.